Concurrent Tracks
November 2-3, 2009

Concurrent Tracks
November 3-4, 2009

Pre Conference
Short Courses
November 1, 2009

Strategies for Effective RNAi Screens

Targeting GPCRs and Ion Channels with Antibodies

Strategies for Optimizing RNAi Delivery

Combating Diabetes with Strategies for Enhanced Pancreatic Beta Cell Survival and Regeneration

Structure-Based Design of Ion Channels

Cardiovascular Safety in Drug Development - From Preclinical to Phase I 

KEYNOTE PRESENTERS

 David Clapham, M.D., Ph.D.,
Howard Hughes Medical Institute





 Michael Dabrowski, Ph.D.,
AstraZeneca





 Gregory J. Kaczorowski,
School; Robert Wood Johnson Medical School





 John M. Maraganore, Ph.D.,
Alnylam Pharmaceuticals, Inc.





 Graeme Milligan, Ph.D.,
University of Glasgow





 Steven E. Nissen, M.D.,
M.A.C.C., Cleveland Clinic Foundation





David Root, Ph.D.,
The RNAi Consortium Broad Institute of MIT and Harvard

Anja J. Stauber, Ph.D., DABT,
Eli Lilly and Company

Eric M. Verdin, M.D.,
University of California, San Francisco